Manasi Barath

TriTACs, a Novel Class of T-Cell–Engaging Protein Constructs Designed for the Treatment of Solid Tumors

Richard J. Austin, Bryan D. Lemon, Wade H. Aaron et al. · Molecular Cancer Therapeutics · 2020 · 55 citations · Full text

A Novel Temozolomide–Perillyl Alcohol Conjugate Exhibits Superior Activity against Breast Cancer Cells <i>In Vitro</i> and Intracranial Triple-Negative Tumor Growth <i>In Vivo</i>

Thomas C. Chen, Hee‐Yeon Cho, Weijun Wang et al. · Molecular Cancer Therapeutics · 2014 · 50 citations

Neuro-oncology, Medicinal Chemistry, Pharmaceutical Chemistry +12

Preclinical and Nonclinical Characterization of HPN217: A Tri-Specific T Cell Activating Construct (TriTAC) Targeting B Cell Maturation Antigen (BCMA) for the Treatment of Multiple Myeloma

Che‐Leung Law, Wade H. Aaron, Rick Austin et al. · Blood · 2018 · 19 citations

HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

Mary E. Molloy, Wade H. Aaron, Manasi Barath et al. · Molecular Cancer Therapeutics · 2024 · 17 citations · Full text

Abstract C033: HPN328: An anti-DLL3 T cell engager for treatment of small cell lung cancer

Wade H. Aaron, Richard J. Austin, Manasi Barath et al. · Molecular Cancer Therapeutics · 2019 · 13 citations

Immunology, Immunoediting, Immunotherapeutics +17